ANI Pharmaceuticals Inc (ANIP) — Cash Flow Reinvestment Rate
ANI Pharmaceuticals Inc (ANIP) has a Cash Flow Reinvestment Rate of 0.79x as of December 2025, reinvesting $23.86 Million (capex $23.86 Million ) from operating cash flow of $30.37 Million. Check ANIP operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ANI Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ANI Pharmaceuticals Inc across 12 annual periods. Explore long-term investment intensity of ANI Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for ANI Pharmaceuticals Inc (2007–2025)
Year-by-year capital reinvestment analysis for ANI Pharmaceuticals Inc. For live market cap and broader valuation context, see ANI Pharmaceuticals Inc (ANIP) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | $13.84 Million | $185.22 Million | $13.84 Million | ▼ -98.9% |
| 2024 | 6.59x | $421.67 Million | $64.02 Million | $16.95 Million | ▲ +2114.4% |
| 2023 | 0.30x | $35.38 Million | $118.96 Million | $18.51 Million | ▼ -99.2% |
| 2021 | 38.87x | $129.12 Million | $3.32 Million | $23.64 Million | ▲ +334.3% |
| 2020 | 8.95x | $136.64 Million | $15.27 Million | $68.32 Million | ▲ +641.2% |
| 2019 | 1.21x | $55.10 Million | $45.63 Million | $27.55 Million | ▲ +111.5% |
| 2018 | 0.57x | $38.29 Million | $67.07 Million | $10.91 Million | ▼ -89.6% |
| 2017 | 5.48x | $215.99 Million | $39.42 Million | $107.99 Million | ▼ -50.3% |
| 2016 | 11.03x | $303.12 Million | $27.47 Million | $149.06 Million | ▲ +482.8% |
| 2015 | 1.89x | $32.68 Million | $17.26 Million | $32.68 Million | ▲ +16.7% |
| 2014 | 1.62x | $35.75 Million | $22.03 Million | $35.75 Million | ▲ +3980.5% |
| 2007 | 0.04x | $29.43K | $739.99K | $29.43K | — |